1,3,4-Thiadiazino[5,6-b]quinoxaline
5
0
0
전체 글
(2) (2003. 4. 7 ). †. †. Synthesis of 1,3,4-Thiadiazino[5,6-b]quinoxalines with Antimicrobial Activity Ho Sik Kim*, Tong Eun Kim, Kyong Hwan Lee, and Yoshihisa Kurasawa† Department of Chemistry, Catholic University of Daegu, Gyongsan 712-702, Korea † School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan (Received April 7, 2003). :. , . 1,3,4-Thiadiazino[5,6-b]quinoxaline ,. Keywords: 1,3,4-Thiadiazino[5,6-b]quinoxalines, Antimicrobial Activity, Algicidal Activity. . @, .8A@B(Chart 2), 5 CD@, . E ./ 3 C -Me F C -Ph! G !, HI 8! 9J! KLM " NMO 2P QRM HI 5 ST 4H-1,3,4-thiadiazino[5,6-b]quinoxline% . T U (. VWO " MO 1,3,4-thiadiazino[5,6-b]quinoxaline % .T XY3 !>@, 2,3-dihydroxyquinoxaline (10) 2,6-dichloroquinoxaline(11)3 Z[/\, ]^ ^_ & `a >?`b quinoxaline '-M 1,3,4thiadiazine '- .E c,d 1,3,4-thiadiazino[5,6b]quinoxaline% .]e@f, .T ./M T 3 g]e. 5,6. 4H-1,3,4-Thiadiazine(1) quinoxaline(2) !"#$ % &' ((Chart 1). ) *+,'- ./0 1/23 & 45 6' 7'89 (. :& 4H-1,3,4thiadiazino[5,6-b]quinoxaline(3) 2,3-dichloroquinoxaline(4) thioacylhydrazine(5); Smiles -<=>? 1-3. 4. 2. 2. 7-9.
(3) . Chart 1.. " NYMO ghT `a ijk3 lm]& n' gh]e@f, ho EPj3 p, gh]e. Z[/ \, ghT 2,3-dihydroxyquinoxaline(10) 2,6LqM rst CD@, dichloroquinoxaline(11) .]e. u-' vw Haake Buchlerg; x& y vw zl{H,| }A', 7l ]& n~. 10. 11,12. Chart 2.. 301.
(4) Yoshihisa Kurasawa. 302. Mattson Polaris FT-IR % g h]^ }A', H NMR Varian Gemini200(200 MHz) % gh]^ }A. u-' Mass Shimadzu GC/MS QP-5000 % gh ]^ }A. IR. 1. 2-Substitutedamino-4H-1,3,4-thiadiazino[5,6-b]quinoxaline. (14) . I! E 100 mL W M ./ 13(1 g, 5 mmol), methyl isothiocyanate(0.56 g, 7.7 mmol), u-' N,N-x 30 mL% ' !MO 2` I`. >?/3 N@, ` 1E '% ^ T N,N-x /MQ, ¡l]^ ¢ £ ¡l$ 2methylamino-4H-1,3,4-thiadiazino[5,6-b]quinoxaline. ¤¥ 46%)3 }A. mp: 240-241 C; o. (14a) 0.53 g(. 1238; MS(m/z): 325(M+), 327(M ++2); 1H NMR(DMSOd6, δ): 11.48(s, 1H, NH), 9.83(s, 1H, NH), 7.94-7.55(m, 4H, aromatic H), 4.25(q, J=7.0 Hz, 2H, CH2), 1.28(t, J=7.0 Hz, 3H, CH3). 6-Chloro-2-[2-(N-substituted thiocarbamoyl)-. (.
(5) ). I! E 100 mL WM . / 17(1 g, 5 mmol), methyl isothiocyanate(0.73 g, 10 mmol), u-' tetrahydrofuran 30 mL% ' /M O 3` I`. ho% °[m± ` /3 ² 1³ ¡l3 ^ ]^ £ ¡l$ 6-chlorohydrazino]quinoxaline 4-Oxide (18). 2-[2-(N-methylthiocarbamoyl)hydrazino]quinoxaline. ¤¥ 69%)3 }A. mp: 223-. 4-oxide(18a) 0.98 g(. 224 oC; IR(KBr, cm−1): 3273, 1576, 1561, 1498, 1391,. IR(KBr, cm−1): 3365, 1639, 1410; MS(m/z): 231(M +);. 1223; MS(m/z): 283(M+), 285(M ++2); 1H NMR(DMSO-. H NMR(DMSO-d6, δ): 10.11(s, 1H, NH), 7.65-7.24. d6, δ): 9.52(s, 1H, NH), 9.48(s, 1H, NH), 8.26(s, 1H,. (m, 4H, aromatic H), 6.63(brs, 1H, NH), 2.70(d, J=4.6. C3-H), 7.90(s, 1H, C5-H), 7.80-7.70(m, 2H, aromatic C7-. Hz, 3H, CH3).. H and C8-H), 2.87(d, J=4.3 Hz, 3H, CH3).. carbonyl isothiocyanate. hydrazino]quinoxaline 4-Oxide(18b). 1. u-', ./ 133 phenyl isothiocyanate F ethoxy >?`b ./ 14b,c% .¦ X§M ./ 14a ¨©ª, ]e@ B, ho MQ3 gh]e. 2-Phenylamino-4H-1,3,4-thiadiazino[5,6-b]quinoxaline (14b). '«£ ¡l@, 0.90 g(¤¥ 61%)3 }A. −1. o. 6-Chloro-2-[2-(N-ethoxycarbonylthiocarbamoyl)-. ´£ ¡l@,. ¤¥ 74%)3 }A. mp: 176-177 C; IR(KBr, o. 1.26 g( −1. cm ): 3210, 1719, 1541, 1478, 1233; MS(m/z): 341(M+), 343(M++2); 1H NMR(DMSO-d6, δ): 11.63(s, 1H, NH), 11.40(s, 1H, NH), 10.52(s, 1H, NH), 8.63(s, 1H, C3-H),. mp: 300 C(dec.); IR(KBr, cm ): 3230, 1637, 1409, 748,. 7.93(s, 1H, C5-H), 7.80-7.40(m, 2H, aromatic C7-H and C8-. 689; MS(m/z): 293(M+); 1H NMR(DMSO-d6, δ): 10.35. H), 4.24(q, J=7.0 Hz, 2H, CH2), 1.28(t, J=7.0 Hz, 3H, CH3).. (s, 1H, NH), 9.05(s, 1H, NH), 7.70-6.87(m, 9H, aromatic H).. . I! E 100 mL WM ./ 17(1 g, 5 mmol), phenyl isothiocyanate (2 g, 14.2 mmol), u-' tetrahydrofuran 30 mL% ' /MO 6` I`. hµ3 N@, ` ¡l3 ^ ]^ p´£ ¡l$ ./ 19(0.72 g, ¤¥ 44%)% }A. mp: 218-219 C;. 2-Ethoxycarbonylamino-4H-1,3,4-thiadiazino[5,6b]quinoxaline(14c). ¬£ ¡l@, 0.79 g(¤¥. 3 }A. mp: 242-243 C; IR(KBr, cm o. 55%). −1. ): 3226,. 1695, 1406; MS(m/z): 289(M ); H NMR(DMSO-d6, δ): +. 1. 10.73(s, 1H, NH), 10.58(s, 1H, NH), 7.64-7.30(m, 4H, aromatic H), 4.12(q, J=7.0 Hz, 2H, CH2), 1.22(t, J=7.0 Hz, 3H, CH3). 1-(3-Chloroquinoxalinyl)-4-ethoxycarbonyl-2-. . I! E 250 mL WM ./ 13(1 g, 5 mmol), ethoxycarbonyl isothiocyanate(1 g, 7.5 mmol), u-' ®,,¯ 50 mL % ' /MO 2` I`. >?/3 N @, ` 1E '% ^ ]^ ¢ £ ¡l$ ./ 15c(0.82 g, ¤¥ 50%)% }A. mp: thiosemicarbazate(15c). 192-193 oC; IR(KBr, cm−1): 3289, 1716, 1544, 1450,. 8-Chloro-2-phenylamino-4H-1,3,4-thiadiazino[5,6-. b]quinoxaline(19). o. −1. IR(KBr, cm ): 3205, 1551, 1345, 1276; MS(m/z): 327(M+), 329(M++2); 1H NMR(DMSO-d6, δ): 10.37(s, 1H, NH), 9.85(s, 1H, NH), 9.15(s, 1H, NH), 8.05(d, J=2.7 Hz, 1H, C9-H), 7.85-6.88(m, 7H, C6-H, C7-H and aromatic H). 7-Chloro-1,2,4-triazolo[4,3-a]quinoxalin-3-ium-1-. thiolate(20) . I! E 100 mL WM ./ 17(0.5 g, 2.4 mmol), phenyl isothiocyanate (1.01 g, 7.1 mmol), u-' N,N-x 20 mL% ' !MO 2` I`. ho% ° Journal of the Korean Chemical Society.
(6)
(7) 1,3,4-Thiadiazino[5,6-b]quinoxaline . 303. [m±` MQ3 ² 1³ ¡l3 ^ ] ^ ¶·£ ¡l$ ./ 20(0.46 g, ¤¥ 81%)3 } A. mp: 250-251 C; IR(KBr, cm ): 3241, 1630, 1560, −1. o. +. 1253, 1193; MS(m/z): 236(M ), 238(M++2); 1H NMR (DMSO-d6, δ): 15.05(brs, 1H, NH), 10.34(d, J=9.0 Hz, 1H, C9-H), 9.15(s, 1H, C4-H), 8.07(d, J=2.4 Hz, 1H, C6H), 7.82(dd, J=2.4, 9.0 Hz, 1H, C8-H).. ¸7 MO 4H-1,3,4-oxadiazino[5,6-b]quinoxaline; .M ]^ 7']e¹, .T ./ MO 3 gT ¡ ./ 6, 7; {º²(Growth Inhibition, %) 500 ppb; » MO Selenastrum capricornutumM ]^ 92.0%, 45.1%, B¼½@f,. ./ 8, 9 Nitzschia closteriumM ]^ 41.0%, 43.2%, 3 B¼¾A(Chart 3). " MO ¸7 MO .T 1,3,4-oxadiazino[5,6b]quinoxaline; oxadiazine '-M ( ¿R À ÁM ´ À HIE 1,3,4-thiadiazino[5,6-b]quinoxaline % .]' 50 ./; 3 g]e. Â, o-ÃÄÅxÆ oxalic acid dihydrate% >?`b } 2,3-dihydroxyquinoxaline(10), u-' 6-chloro-2quinoxalinone3 phosphoryl chloride, ÇR >?`b } 2,6-dichloroquinoxaline(11)3 Z[/\, ]^ 5 03 ^_ & `a >?`b 1/# 25 ! 8 1,3,4-thiadiazino[5,6-b]quinoxaline; .3 ` ]e¹, 50; .X, .. ./ 103 phosphorous pentachloride, ÇR > ?`b ¡È3 t 2,3-dichloroquinoxaline(12)3 .T , hydrazine hydrate, hydrazinolysis` b 2-chloro-3-hydrazinoquinoxaline(13)3 .]e. 543 isothiocyanate N,N-x É 13. 13. 14-16. 17. Scheme 1.. MQ ho]MO >?`b 2-methylamino-4H-1,3,4thiadiazino[5,6-b]quinoxaline(14a), 2-phenylamino-4H1,3,4-thiadiazino[5,6-b]quinoxaline(14b). 3 .]e(Scheme 1). uʹ, ./ 133®,,¯ ho]MO ethoxycarbonyl isothiocyanate >?`ËÌ ÍlT ./$ 1-(3(14c). chloroquinoxalinyl)-4-ethoxycarbonyl-2-thiosemi-. carbazate(15c) 18A',543 MQ ho]MO I`ËÌ ¾ '- >?M ;² ./ 14c 1 8A. u_B ./ 133 methyl isothiocyanate É phenyl isothiocyanate ®,,¯ ho]MO >? `ËÎ ./ 15b,c -8& n' 50; % ±Ï ¾ '- >?5 Ð9BO ./ 14b,c 1 8A. ./ 14; Ñ$ ./ 13; H NMR MO B¼½Ò 4.69-4.62 ppmMO; ¬! ; Ó5 B¼B& n 4 IR F MS Ô@, Ñ$]e@f, ./ 15c IR MO 1716 cm MO B¼Õ Ö×7Ä!; ØÙ H NMR F MS Ô@, Ñ$]e. 5PM 57' ECD@, 2,6-dichloroquinoxaline(11)3 Z[/\, ]^ m-chloroperbenzoic acid (MCPBA) >?`b 2,6-dichloroquinoxaline 4-oxide (16)% .T hydrazinolysis`b 6-chloro-2hydrazinoquinoxaline 4-oxide(17)% .]e. ./ 173 isothiocyanate >?`b 6-chloro-2-[2-(N1. −1. 1. 11,12,18. Chart 3. 2003, Vol. 47, No. 3. F 2-ethoxycar-. bonylamino-4H-1,3,4-thiadiazino[5,6-b]quinoxaline.
(8) Yoshihisa Kurasawa. 304. Scheme 3. Scheme 2.. methylthiocarbamoyl)hydrazino]quinoxaline 4-oxide(18a), 6chloro-2-[2-(N-ethoxycarbonylthiocarbamoyl)-hydrazino]-. F 8-chloro-2-phenylamino4H-1,3,4-thiadiazino[5,6-b]quinoxaline(19)3 .]e quinoxaline 4-oxide(18b) (Scheme 2).. ./ 173 methyl isothiocyanate É ethoxycarbonyl isothiocyanate tetrahydrofuran ho]MO >?`Ë Î ./ 18a,b 18A. u_B ./ 173 phenyl isothiocyanate tetrahydrofuran ho]MO > ?`ËÎ ./ 19 18A. quinoxaline N-oxide ; α-QR N-oxide moietyM N >?5 Ð9Õ ÚÈ ÛÜ5 ÝÞ Ð9B¹, " MO u_T ß5 ๠./ 19 18A. u' ho% N,N-x% gh]Ì ./ 185 -8& n' A, B% ±Ï R 5á. ./ $ 7-chloro-1,2,4-triazolo[4,5-a]quinoxalin3-ium-1-thiolate(20) 18A. 54 ho; â KLM triazole '- 1E 4@, ã (. u' phenyl isothiocyanate y¿Rm ,O y¿R Ö ÎäM å^ ]e¹, >? ÖÎä 3,7,9. 9,19-22. 23. (Scheme 3).. .T ./ MO ./ 15c Bacillus subtilisM ]^æR[çº&» (Minimum Inhibitory Concentration: MIC, ppm) >10 ppm@, 3 B¼¾A', . / 19 Bacillus subtilis, Rhodotorula mucilaginosa, Trichophyton mentagrophytesM ]^ MIC >10 ppm@, F t3 B¼¾A. u' ./ 14a, 15c; {º²(Growth Inhibition, %). 500 ppb; » MO Selenastrum carpricornutumM ]^ 93.2%, 42.1%, B¼½@f, ./ 14c Selenastrum capricornutum, Nitzschia closteriumM ]^ 93.0%, 86.5%, 3 B¼¾A. " 2003è ª & ÀM ;]^ é8A@f, M T screening test
(9) êëìíîïðñ(Ð")M ;]^ é8A!M g; òó3 ôÎ.. 1. (a) Smalley, R. K. Comprehensive Heterocyclic Chemistry II; Katrizky, A. R., Rees, C. W., Scriven, E. F. V., Eds.; Pregamon Press : Oxford, U. K., 1996; Vol. 6, pp 737-781. (b) Sato, N. Comprehensive Heterocyclic Chemistry II; Katrizky, A. R., Rees, C. W., Scriven, E. F. V., Eds.; Pregamon Press: Oxford, U. K., 1996; Vol. 6, pp 234-278. (c) Cheeseman, G. W. H.; Cookson, R. F. The Chemistry of Heterocyclic Compounds. Condensed Pyrazines; Weissberger, A., Taylor, E. C., Eds.; John Wiley & Sons: New York, U. S. A., 1979; pp 1-290. 2. Kurasawa, Y.; Takada, A.; Kim, H. S. J. Heterocyclic Chem. 1995, 32, 1085. 3. Kim, H. S.; Kurasawa, Y. Heterocycles 1998, 49, 557. 4. Elliott, A. J.; Gibson, M. S.; Kayser, M. M.; Pawelchak, G. A. Can. J. Chem. 1973, 51, 4115. 5. Elliott, A. J. J. Heterocyclic Chem. 1981, 18, 799. 6. Elliott, A. J. U. S. Patent 1997, 4025510 ; Chem. Abstr. 1997, 87, 153420h. 7. Kurasawa, Y.; Sekine, M.; Kim, H. S.; Okamoto, Y. J. Heterocyclic Chem. 1996, 33, 1859. 8. Kim, H. S.; Okamoto, Y.; Kurasawa, Y. J. Heterocyclic Journal of the Korean Chemical Society.
(10)
(11) 1,3,4-Thiadiazino[5,6-b]quinoxaline Chem. 1997, 34, 1029. 9. Kim, H. S.; Kim, T. E.; Kwag, S. T.; Park, Y. T.; Hong, Y. S.; Okamoto, Y.; Kurasawa, Y. J. Heterocyclic Chem. 1997, 34, 1539. 10. Mager, H. I. X.; Berends, W. Rec. Trav. Chim. PaysBas 1958, 77, 842. 11. Sakata, G.; Makino, K. Chem. Lett. 1984, 323. 12. Makino, K.; Sakata, G.; Morimoto, K.; Ochiai, Y. Heterocycles 1985, 23, 2025. 13. Kim, T. E.; Kim, H. S. J. Korean Chem. Soc. 1998, 42, 449. 14. Cheeseman, G. W. H. J. Chem. Soc. 1962, 1170. 15. Tomoda, H.; Saito, S.; Ohishi, M.; Shiraishi, S. Nippon Kagaku Kaishi 1989, 2059. 16. Asano, K. Yakugaku Zasshi 1958, 78, 729. 17. Reddy Sastry, C. V.; Krishman, V. S. H.; Narayan, G.. 2003, Vol. 47, No. 3. 305. K. A. S. S.; Vemana, K. Ind. J. Chem. 1991, 30B, 936. 18. Kim, H. S.; Kurasawa, Y.; Yoshii, C.; Masuyama, M.; Takada, A.; Okamoto, Y. J. Heterocyclic Chem. 1990, 27, 1111. 19. Newton, C. G.; Ramsden, C. A. Tetrahedron 1982, 38, 2965. 20. Friedrichsen, W.; Kappe, T.; Bottcher, A. Heterocycles 1982, 19, 1083. 21. Kurasawa, Y.; Kawano, T.; Katoh, A.; Takada, A.; Kim, H. S.; Okamoto, Y. J. Heterocyclic Chem. 1992, 29, 1337. 22. Buccheri, F.; Cusmano, G.; Gruttadauria, M.; Noto, R.; Werber, G. J. Heterocyclic Chem. 1997, 34, 1447. 23. Kurasawa, Y.; Yoshishiba, N.; Kureyama, T.; Okano, T.; Takada, A.; Kim, H. S.; Okamoto, Y. J. Heterocylic Chem. 1992, 29, 1653..
(12)
관련 문서
해설 교차로나 그 부근에서 긴급자동차가 접근하는 경우에는 차마와 노면전차의 운전자는 교차로를 피하여 일시정지 하여야 한다.. 27.> 모든 차와 노면전차의
본 연구원에서는 공개채용 서류접수와 관련하여 귀하의 개인정보를 아래와 같이 수집·이용하고자 합니다. 수집된 개인정보는 채용업무
멘토링 과정에서는 많은 어려움이 발생하기 때문에 초지일관 자신 감과참을성을 가지고 끈질기게 멘토링에 참여하는 것이 필요하다. 계획된 멘토링에 진지하고 헌신적으로
Months 1, 3, and 5: methylprednisolone 1 g/day IV for 3 days followed by 0.4 to 0.5 mg/kg/day orally for 27 days Months 2, 4, and 6: cyclophosphamide 2.0 to 2.5
http://blog.naver.com/op2330
채점 기준 민영이가 추론한 방법을 잘 파악하여 자신의 경험을 떠올렸다는 내용으로 썼으면 정답으로 합니다... 5 첫 번째 문단에 글쓴이의
*단어 사이의 공통성과
3) Galaxy Zoo: Mergers 4) Protein Modeling 5) Online Data Challenges 1) Milky Way Project 2) modeling Lens Candidates.. 3) Galaxy Zoo: Mergers 4) Protein Modeling 5)